• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中间葡萄膜炎的长期视力预后及相关并发症

Long-term visual outcome and complications associated with pars planitis.

作者信息

Malinowski S M, Pulido J S, Folk J C

机构信息

Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City.

出版信息

Ophthalmology. 1993 Jun;100(6):818-24; discussion 825. doi: 10.1016/s0161-6420(93)31567-8.

DOI:10.1016/s0161-6420(93)31567-8
PMID:8510893
Abstract

PURPOSE

To identify the ocular complications and to statistically evaluate the possible association of pars planitis with multiple sclerosis (MS) in a homogeneous population of pars planitis patients.

METHODS

The authors reexamined 36 patients and reviewed the records of an additional 18 patients (total: 54 patients, 108 eyes) with idiopathic pars planitis.

RESULTS

The initial mean visual acuity of 20/46 (logMAR: 0.36 +/- 0.50) was not statistically different from the final mean visual acuity of 20/44 (logMAR: 0.34 +/- 0.45; P = 0.73), after a mean follow-up of 89.2 months. Complications included neovascularization with or without associated vitreous hemorrhage (7 eyes, 6.5%), moderate to severe cellophane retinopathy (7 eyes, 6.5%), chronic cystoid macular edema (CME) (9 eyes, 8.3%), visually significant cataracts (16 eyes, 14.8%), and retinal detachment (9 eyes, 8.3%). Significant lens opacification was associated with a greater risk of retinal detachment (P = 0.004). In four patients (7.4%), optic neuritis developed, and in an additional eight patients (14.8%) MS developed. Kaplan-Meier analysis of these data showed a 16.2% +/- 6.2% risk of MS solely developing in patients, and a 20.4% +/- 6.7% risk of either MS or optic neuritis developing, after 5 years of disease. The presence of periphlebitis at the time of pars planitis diagnosis increased the rate of development of these conditions (P = 0.002). Six patients (11.1%) had a family history positive for MS in a first-degree relative.

CONCLUSIONS

This study demonstrates the overall favorable visual prognosis in patients with pars planitis. Patients with significant cataract formation appear to be at greater risk for retinal detachment. Periphlebitis at the time of diagnosis of pars planitis increases the risk of development of optic neuritis or MS. The strong association demonstrated between pars planitis and MS in this study further supports a link between the two disease states.

摘要

目的

在一组同质的中间葡萄膜炎患者中,确定眼部并发症,并对中间葡萄膜炎与多发性硬化症(MS)之间可能的关联进行统计学评估。

方法

作者对36例患者进行了复查,并回顾了另外18例特发性中间葡萄膜炎患者的病历(共54例患者,108只眼)。

结果

平均随访89.2个月后,初始平均视力20/46(logMAR:0.36±0.50)与最终平均视力20/44(logMAR:0.34±0.45;P = 0.73)无统计学差异。并发症包括伴或不伴玻璃体出血的新生血管形成(7只眼,6.5%)、中度至重度玻璃纸样视网膜病变(7只眼,6.5%)、慢性黄斑囊样水肿(CME)(9只眼,8.3%)、具有视觉意义的白内障(16只眼,14.8%)和视网膜脱离(9只眼,8.3%)。明显的晶状体混浊与视网膜脱离风险增加相关(P = 0.004)。4例患者(7.4%)发生视神经炎,另外8例患者(14.8%)发生MS。对这些数据进行Kaplan-Meier分析显示,疾病发生5年后,患者单独发生MS的风险为16.2%±6.2%,发生MS或视神经炎的风险为20.4%±6.7%。中间葡萄膜炎诊断时存在静脉周围炎会增加这些疾病的发生率(P = 0.002)。6例患者(11.1%)的一级亲属中有MS家族史阳性。

结论

本研究表明中间葡萄膜炎患者总体视力预后良好。有明显白内障形成的患者似乎发生视网膜脱离的风险更高。中间葡萄膜炎诊断时的静脉周围炎会增加视神经炎或MS发生的风险。本研究中中间葡萄膜炎与MS之间显示的强关联进一步支持了这两种疾病状态之间的联系。

相似文献

1
Long-term visual outcome and complications associated with pars planitis.中间葡萄膜炎的长期视力预后及相关并发症
Ophthalmology. 1993 Jun;100(6):818-24; discussion 825. doi: 10.1016/s0161-6420(93)31567-8.
2
Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis.伴有睫状体平坦部炎的视网膜前膜行玻璃体平坦部切除术后的视觉预后
Ophthalmology. 1999 Jun;106(6):1086-90. doi: 10.1016/S0161-6420(99)90247-6.
3
Pars planitis: a 20-year study of incidence, clinical features, and outcomes.中间葡萄膜炎:一项关于发病率、临床特征及预后的20年研究。
Am J Ophthalmol. 2007 Dec;144(6):812-817. doi: 10.1016/j.ajo.2007.08.023.
4
Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children.特发性平坦部睫状体炎相关的囊样黄斑水肿对儿童视力预后和治疗的影响。
Graefes Arch Clin Exp Ophthalmol. 2020 Aug;258(8):1803-1811. doi: 10.1007/s00417-020-04696-7. Epub 2020 Apr 28.
5
Analysis of clinical features and visual outcomes of pars planitis.睫状体平坦部炎的临床特征及视力预后分析。
Int Ophthalmol. 2018 Apr;38(2):727-736. doi: 10.1007/s10792-017-0526-2. Epub 2017 Apr 7.
6
Cataract extraction in patients with pars planitis.
Ophthalmology. 1993 Aug;100(8):1210-7. doi: 10.1016/s0161-6420(93)31503-4.
7
Pars planitis: epidemiology, treatment, and association with multiple sclerosis.
Ocul Immunol Inflamm. 2001 Jun;9(2):93-102. doi: 10.1076/ocii.9.2.93.3975.
8
Pars planitis: clinical features and class II HLA associations.
Ophthalmology. 1999 Mar;106(3):594-9. doi: 10.1016/S0161-6420(99)90122-7.
9
Outcomes of cataract surgery with/without vitrectomy in patients with pars planitis and immunosuppressive therapy.伴有或不伴有玻璃体切除术的白内障手术在中间葡萄膜炎患者及免疫抑制治疗中的疗效。
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1213-1219. doi: 10.1007/s00417-017-3658-1. Epub 2017 Apr 10.
10
Peripheral Cryoablation for Treatment of Active Pars Planitis: Long-Term Outcomes of a Retrospective Study.外周冷冻消融术治疗活动期睫状体平坦部炎:一项回顾性研究的长期结果
Am J Ophthalmol. 2016 Feb;162:35-42.e2. doi: 10.1016/j.ajo.2015.11.009. Epub 2015 Nov 11.

引用本文的文献

1
[Uveitis and multiple sclerosis : Clinical aspects, diagnostics, management and treatment].[葡萄膜炎与多发性硬化症:临床方面、诊断、管理与治疗]
Ophthalmologie. 2024 Aug;121(8):665-678. doi: 10.1007/s00347-024-02084-8. Epub 2024 Jul 22.
2
Demyelinating plaque-associated uveitis.脱髓鞘斑块相关性葡萄膜炎。
Graefes Arch Clin Exp Ophthalmol. 2024 Feb;262(2):575-582. doi: 10.1007/s00417-023-06270-3. Epub 2023 Oct 19.
3
Clinical characteristics of intermediate uveitis in adults according to criteria of the SUN working group.
根据 SUN 工作组的标准,成人中间葡萄膜炎的临床特征。
Int Ophthalmol. 2023 Oct;43(10):3681-3693. doi: 10.1007/s10792-023-02778-z. Epub 2023 Jul 3.
4
[Vascular retinal alterations as the key for the diagnosis of a longstanding disease].[视网膜血管改变作为一种长期疾病诊断的关键]
Ophthalmologie. 2023 Sep;120(9):961-964. doi: 10.1007/s00347-023-01860-2. Epub 2023 May 4.
5
Total exudative retinal detachment in a child with pars planitis- a challenging case with optimistic results.一名患有睫状体平坦部炎的儿童出现完全渗出性视网膜脱离——一个具有挑战性但结果乐观的病例。
J Ophthalmic Inflamm Infect. 2023 Feb 27;13(1):6. doi: 10.1186/s12348-023-00328-3.
6
Effect of fingolimod therapy on quantitative macular changes among patients with relapsing-remitting multiple sclerosis: a four-year follow-up study from Oman.在奥曼进行的一项为期四年的随访研究中,发现芬戈莫德治疗对复发缓解型多发性硬化症患者的定量黄斑变化有影响。
BMC Ophthalmol. 2022 Dec 5;22(1):470. doi: 10.1186/s12886-022-02701-7.
7
Uveitis in Children and Adolescents.儿童和青少年的葡萄膜炎。
Rheum Dis Clin North Am. 2021 Nov;47(4):619-641. doi: 10.1016/j.rdc.2021.07.005. Epub 2021 Aug 27.
8
Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.多发性硬化相关性中间葡萄膜炎的分类标准。
Am J Ophthalmol. 2021 Aug;228:72-79. doi: 10.1016/j.ajo.2021.03.044. Epub 2021 May 11.
9
Classification Criteria For Pars Planitis.帕斯卡氏眼病分类标准。
Am J Ophthalmol. 2021 Aug;228:268-274. doi: 10.1016/j.ajo.2021.03.045. Epub 2021 Apr 15.
10
Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type.中间葡萄膜炎,非结节性视网膜血管炎型的分类标准。
Am J Ophthalmol. 2021 Aug;228:159-164. doi: 10.1016/j.ajo.2021.03.054. Epub 2021 Apr 9.